A Candida albicans peptide transport gene, albicans genomic library by functional complementation of a peptide transport deficient mutant (strain pW2-2) of Sacchammyces cemvisiae. CamR2 restored peptide transport t o transformants as determined by uptake of radiolabelled dileucine, growth on dipeptides as sources of required amino acids, and restoration of growth inhibition by toxic peptides. Plasmid curing experiments demonstrated that the peptide transport phenotype was plasmid borne. CaPTR2 was localized to chromosome R of C. albicans by contour-clamped homologous electric field gel chromosome blots. Deletion subclones and frameshift mutagenesis were used to narrow the peptide transport complementing region to a 5 1 kb DNA fragment. DNA sequencing of the complementing region identified an ORF of 1869 bp containing an 84 nucleotide intron. The deduced amino acid sequence predicts a protein of 70 kDa consisting of 623 amino acids with 12 hydrophobic segments. A high level of identity was found between the predicted protein and peptide transport proteins of S. cemvisiae and Arabidopsis thaliana. This study represents the first steps in the genetic characterization of peptide transport in C. albkans and initiates a molecular approach for the study of drug delivery against this pathogen.
INTRODUCTION
Studies from our laboratory and several others have characterized the peptide transport systems of Candida albicans and Saccbaromyces cerevisiae (for reviews see Becker & Naider, 1980; . Results from these studies suggested that both yeasts contain peptide permeases with structural requirements that differ from those of bacterial and mammalian peptide permeases (for reviews see Matthews, 1991 ; Payne, 1980) . Though yeasts show optimal growth on peptides containing hydrophobic residues, they lack strict specificity, as indicated by their ability to transport modified peptides . Peptide transport systems in yeasts are t m n t address: Department of Molecular Biology and Genetics, Johns
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regulated by nitrogen metabolism , and are induced by the addition of micromolar amounts of certain amino acids (Basrai e t al., 1992 ; Island et al., 1991). In an effort to define peptide transport at the genetic level, S. cerevisiae strains resistant to the growth-inhibitory effects of the dipeptide alanyl-ethionine (Ala-Eth) were isolated (Island e t al., 1991). These strains defined three complementation groups suggesting that peptide transport in S. cerevisiae is mediated by at least three genes, PTR 7, PTRZ and PTRP (Peptide TRansport). Mutations in PTR7 and PTRZ genes make the cells peptidetransport-deficient, whereas mutations in the P TR3 gene result in an intermediate phenotype characterized by lowlevel transport of radiolabelled dipeptides. We have cloned and characterized the S. cerevisiae PTR7 (Alagramam et al., 1995) and PTRZ (Perry et al., 1994) genes which have ORFs of 5850 and 1803 bp, respectively. The deduced amino acid sequence of the S. cerevisiae Ptr2p suggests a membrane protein with 12 transmembrane domains. PTR7 was found to be identical to S. cerevisiae UBR7, the recognition component of the N-end rule pathway which is a ubiquitin-dependent protein-degradation system (Alagramam et al., 1995 ;  Bartel e t al., 1990).
Our working hypothesis is that PTR2 encodes the structural component of the peptide transport system while PTR I / UBR 7 is responsible for regulation.
Current evidence, though not conclusive, suggests the presence of at least two peptide permeases in C. albicans.
One of the systems mediates transport of di-and tripeptides, whilst the other transports tri-and oligopeptides . A definitive characterization of the number and role of peptide permeases in C. albicans and their regulation will require combined genetic and biochemical approaches. Cloning of the genes involved in peptide transport in C. albicans will enable the comparative analysis of the structure and physiological role of membrane transporters from different organisms. Previously, peptide conjugates have been used to deliver toxic moieties to C. albicans via the peptide transport system . Synthetic analogues of the polyoxins and nikkomycins, which inhibit chitin synthase (Cabib, 1991) , have also been designed to enter C. albicans through the peptide transport system . Hence, these studies may facilitate the design of an effective and specific anticandidal drug by exploiting the concept of ' illicit transport' (Ames e t al., Fickel & Gilvarg, 1973; Hammond et al., 1987; Higgins, 1987) in this opportunistic pathogen.
The diploid nature of the C. albicans genome and the absence of a known sexual cycle have limited genetic studies with this organism. Nevertheless, significant advances have been made in the past few years towards the genetic manipulation of C. albicans. Many C. albicans genes have been cloned by functional complementation of S. cerevisiae mutants, by nucleotide homology, or by conferring a unique phenotype on the cells (reviewed in Kurtz e t al., Scherer & Magee, 1990 ). Here we report the cloning of a C. albicans peptide transport gene by functional complementation of a S. cerevisiae peptide transport mutant.
METHODS
Strains, vectors and media. The S. cerevisiae strains used in this study were PBlX-9B (MATa ura3-52 leu2-3,112 hs1-1 his4-38 ptrZ-Z), PB3X-5C (MATa ura3-52 leu2-3,112 bsl-1 his4-38ptr2-I ) , and PB1 X-2A (MATa ura3-52 leu2-3,112 bsl-1 his4-38, P TRZ). These strains were constructed as described previously (Perry et al., 1994 (Altboum et al., 1990) . C. albicam and S. cerevisiae cells were maintained on YEPD medium containing (w/v): peptone 2 % ; glucose 2 % ; yeast extract 1 % ; agar (Difco) 2 %. The minimal medium (MM) used for most studies was made by adding 10 ml 10 x filter-sterilized YNB without amino acids and without ammonium sulfate (Difco), to 90 ml sterile water containing 2 g glucose, 100 mg allantoin and auxotrophic supplements depending on the strain as follows: histidine (20 mg 1-' ), uracil (20 mg 1-' ), lysine (30 mg 1-' ) and leucine (30 mg 1-' ) (Sherman e t al., 1986) . Allantoin, a purine catabolite which can serve as the sole nitrogen source for S. cerevisiae, was used in MM as it is neutral with respect to peptide transport activity, whereas other nitrogen sources, such as ammonium sulfate and amino acids, affect peptide transport (Basrai e t a/., 1992; Island et al., 1987). The mutant strain S. cerevisiae PB1 X-9B was grown in Complete Medium (CM), which consisted of MM with histidine, uracil, lysine and leucine. S. cerevisiae PB1 X-9B transformed with YEp24-based plasmids was grown on CM lacking uracil (CM-Ura) and those transformed with pRS201-based plasmids were grown on CM lacking leucine (CM-Leu) medium. Dipeptide medium [His-Lys, Lys-Met, Lys-Lys, His-Leu, LeuMet, Leu-Leu, or Lys-Leu (80pM)I consisted of MM supplemented with the auxotrophic requirements minus the amino acid components of the added peptides. For example, the dipeptide (Lys-Leu) medium for the growth of S. cerevisiae PB1 X-9B transformed with the P TR2 gene on a Y Ep24 plasmid contained MM supplemented with Lys-Leu and histidine. To determine the auxotrophic markers, ' drop-out ' plates were made which consisted of MM with all the auxotrophic supplements except the one being tested. E. coli cells used for transformation were grown in LB medium (Sambrook et al., 1989) . Enzymes, chemicals and reagents. ~-Leucyl-~-[~H]leucine, Ala-Eth and oxalysine-containing peptides were synthesized by standard solution-phase techniques (Becker & Naider, 1977 ; Naider e t al., 1983) and have been described previously (Basrai et al., 1992; Island et al., 1991) . Eth and the dipeptides were obtained from Sigma. Oxalysine, a toxic analogue of lysine, was a gift from Hong-Long Zhang of Shanghai Institute of Materia Medica, Academia Sinica, Shanghai 20021 , China. Polyoxin D was purchased from Calbiochem ; restriction endonucleases, T4 DNA ligase, T4 DNA polymerase and alkaline phosphatase were purchased from BRL, New England BioLabs or Promega, and were used according to the manufacturers' specifications. DNA manipulations. Small-scale plasmid DNA preparations from E. coli transformants were as described in Sambrook et al. (1989) , except that cultures were grown in modified Terrific Broth containing 50 pg ampicillin ml-'. Large amounts of plasmid DNA were obtained using the p2523 column chromatography protocol (5Prime + 3Prime, Inc.). Plasmid DNA from S. cerevisiae transformants was obtained as described by Sherman e t al. (1986) . Whole-cell DNA from S. cerevisiae was obtained as described by Ausubel et al. (1990) . All agarose gels were prepared in 1 x TAE buffer (40 mM Tris acetate and 1 mM EDTA, pH 8.0). E . coli cells were transformed using the Hanahan procedure described in Sambrook et al. (1989) . Yeast transformations were done using the procedure described by Gietz et al. (1991) and plates were incubated at 30 OC for 4 d or longer. For Southern analyses whole-cell DNA was digested with restriction enzymes and electrophoresed on 0.9 % agarose gels (1-1-5 V cm-' for 14-18 h). Lambda DNA digested with Hind111 was used as a size marker. Southern blotting was done as described in Sambrook e t al. (1989) . A PCR-amplified 980 bp fra ment internal to CuPTR2 (see Fig. lb Cells were then plated on YEPD plates to obtain isolated colonies which were picked, washed with water and resuspended to 1 x lo7 cells m1-l. Three microlitres of the cell suspension was spotted as described in growth assays on appropriate media and checked for the auxotrophic markers, sensitivity to ethionine and Ala-Eth, and the ability to grow on dipeptides. Several subclones were generated from plasmid pMB3 ( Fig. la) to determine the minimum C. albicuns DNA fragment that could functionally complement the S. cereuisiaeptr2 mutation (Fig. 1 b) .
Plasmids pMCl , pMC2 and pMC7 were derived from pMB3 by ligation of insert DNA into plasmid pRS201 (Sikorski & Hieter, 1989) . Plasmid pMCl contained a 3.2 kb HindIII fragment of the insert DNA and pMC2 contained a 2.9 kb HindIII fragment (with 348 bp of flanking vector DNA). Plasmid pMC7 contained a 2 1 kb PstI-Hind111 fragment from pMB3 ligated to the PstI-Hind111 site of pRS201. Plasmids pMC9 and pMCll contain frameshift mutations at the BgfII site and KpnI site, respectively, and were generated by cleavage with the appropriate restriction enzyme, conversion to blunt ends with T4 DNA polymerase and ligation. Plasmid pMC12 was constructed by deletion of 2.4 kb NheI-KpnI fragment from pMB3 while plasmid pMC13 was constructed by deletion of the 1-1 kb MluI-BamHI fragment from pMCl2. The constructed plasmids were then used to transform strain PBlX-9B. A two-step selection was done in which transformants were first plated on CM-Leu medium for constructs with LEU2 marker (pRS201) or CM-Ura for constructs with U R A 3 marker (YEp24). LEU' and URA+ transformants were then plated on dipeptide medium containing Lys-Leu with other auxotrophic requirements minus the amino acid components of the dipeptide. The entire 5.1 kb subclone corresponding to pMC13 that contained CaPTRZ was sequenced. Sequencing was done using the fluorescent dideoxy-terminator method of cycle sequencing on an Applied Biosystems 373A automated DNA sequencer, following the manufacturer's protocols (McCombie et af., 1992 ; Smith et al., 1986) . Both strands were sequenced using primers to fully confirm the order of bases. The DNA sequencing for this analysis was done at the DNA analysis facility of Johns Hopkins University, School of Medicine. Growth and transport assays. Growth assays to determine the phenotype of the cells was done as described by Island et al. (1991) . Briefly, 3 pl of culture from a suspension of 1 x lo7 cells ml-' was applied to the surface of the medium and plates were incubated at 30 O C for 48 h or longer. Uptake of ~-leucyl-~-[~H]leucine was determined as described by Basrai et al. (1992) . The final concentration of the components in the uptake assay was: glucose (2 %, w/v), 4 mM sodium citrate/potassium phosphate buffer (pH 5.5), and L-leucyl-L-[3H]leucine (10 pM; 20 mCi mmol-'; 740 MBq mmol-l). Competition experiments were done in the presence of either 1.0 mM L-leucine or 1.0 mM L-leucyl-L-leucine. There was no peptide adsorption to the cell surface or sticking to filters since at 0 OC the counts were at background level. Each point on the uptake curve represents the mean of three independent determinations whose values did not vary more than 15 % from the mean value.
The uptake results, calculated on the basis of 50% counting efficiency (determined using ~-['H]lysine as a standard, and the specific activity of the peptide), are expressed as nmol peptide uptake per mg cell dry weight. Sensitivity assays. Sensitivity to ethionine, Ala-Eth, oxalysine and oxalysine-containing peptides was determined as described by Island et af. (1987) . Zones of inhibition were measured after 24 h incubation at 30 OC. Each test comprised at least three independent assays and the results represented in the Tables are means of the values obtained. Maximum variation between the zones of inhibition measured for each test was < 2 mm. A value of 7 mm for the diameter of zone of inhibition represents a minimal growth inhibition value as the disk diameter was 6 mm.
Sensitivity to polyoxin D was determined using a liquid assay as described by Cabib (1991) . Briefly, cells were grown overnight in YNB supplemented with lysine (30 mg ml-l) and leucine (30 mg ml-l) to a density of approximately 1 x lo7 cells ml-'. The cultures were diluted to 1 x 10' cells ml-' in fresh growth medium with or without 750pg polyoxin Dml-' and incubated at 30 OC for 5 h. Appropriate dilutions of the cultures were plated on CM-Ura medium, incubated at 30 OC for 36 h and colonies were counted.
RESULTS

Cloning of a C. albicans peptide transport gene
We screened a C. albicans genomic library in YEp24 to determine if the ptr2 mutation in S. cerevisiae could be functionally complemented by a C. albicans gene. The host for transformation was the S. cerevisiae ptr2-2 mutant, strain PBlX-gB, which is resistant to the toxic dipeptide Ala-Eth, fails to accumulate radiolabelled dileucine at wild-type levels, and is unable to use dipeptides to satisfy its auxotrophic requirement for amino acids. A two-step selection was utilized in which S. cerevisiae transformants were first plated to select for uracil prototrophs. The URA3' transformants were then plated and scored for the ability to grow on dipeptide medium: MM containing histidine and the dipeptide Lys-Leu in place of the lysine and leucine. This strategy precluded the complementation of the amino acid auxotrophies by homologous C. albicans LYS and LEU genes, and provided strong selective pressure for isolation of peptide transport genes. Histidine in the dipeptide medium served to supplement for the his4-38 mutation in PBlX-9B and induce the peptide transport system (Basrai et al., 1992; Island e t al., 1987) . Approximately 15 000 S. cerevisiae URA3' transformants were obtained after transformation of strain PB1 X-9B with 1.5 pg DNA from the C. containing deletions, subclones or frameshift mutations were derived from plasmid pMB3 as described in Methods, and tested for their ability t o complement the 5. cerevisiae ptr2-2 mutation in strain PBlX-9B. Ability of each plasmid t o functionally complement the ptr2-2 mutation is represented as a plus (+) or lack of complementation as a minus (-) . Frameshift mutations at the Bglll site in plasmid pMC9, and at the Kpnl site in plasmid pMCl1, are indicated by a triangle with +4 t o denote the frameshift after the site was filled in with Klenow. The PCR-generated probe used in the Southern blots is marked as such.
transformants and was used to transform E. coli HB101. Restriction enzyme analysis of the plasmids from the E. coli transformants showed that two different plasmids, pMB3 and pMB5, were isolated, with inserts of 8.7 kb and 11-2 kb, respectively. A partial restriction enzyme map of the 8.7 kb insert in plasmid pMB3 was determined (Fig.  la) . The 8.7 kb insert of pMB3 was also present in plasmid pMB5 (data not shown). Plasmids were amplified and used to transform the mutant strain S. cerevisiae PBlX-9B. Both plasmids, pMB3 and pMB5, were capable of complementing theptr2-2 mutation in strain PB1 X-9B. It was thus concluded that the 8-7 kb DNA fragment present in plasmid pMB3 probably contained the entire C. albicans CaPTRZ gene. Deletion and frameshift analyses were used to localize the PTRZ complementing region to a 5.1 kb insert contained in plasmid pMC13 (Fig. lb) . Plasmids pMB3 and pMC13 were able to functionally complement the ptr2 mutation in PB3X-9CY an independently isolatedptrz-7 mutant, and PB1 X-2AAY a PTRZ deletion strain. A plasmid-curing experiment showed that the primary S. cerevisiae transformants (obtained after transformation with the C. albicans library) and secondary S. cerevisiae transformants (obtained after transformation with a plasmid isolated from the primary transformants and shuttled through E. coli) had lost both the U R A 3 marker and the PTR' phenotype. This suggested that the phenotype of the S. cerevisiae transformants carrying plasmid pMB3 was due to a plasmid-borne gene and not due to a reversion of the ptr2-2 allele.
Transport of ~-leucyl-~-[~HH]leucine in 5. cerevisiae transformants
Neither strain PB1 X-9B nor PB1 X-2AA accumulated radioactivity from labelled dileucine (Island e t al., 1991 , Perry e t al., 1994). PBIX-2AA carrying plasmid YEp24 was also unable to transport dileucine (Fig. 2) . In contrast, both the wild-type strain PBlX-2A carrying the YEp24 shuttle vector and PB1 X-2AA transformed with pMB3 showed similar high levels of dipeptide uptake (Fig. 2) . The uptake of radioactive dileucine was competed by unlabelled dileucine but not by leucine (data not shown). These results show that pMB3 restored peptide transport Maximum variation between the zones of inhibition for each test was < 2 mm.
t The outline of the zone of inhibition was not very sharp and a hazy zone of inhibition was observed (see Fig. 3 ).
function to the mutant strain, and that dileucine enters through a transport system distinct from the amino acid permease(s). The initial rate of peptide transport in strain PBlX-2AA(pMB3) was equal to the wild-type level, but the total accumulation was lower upon longer incubation of the cells.
Dipeptides as growth substrates for S. cerevisiae transformants
Growth assays showed that the mutant strains PBlX-9B (PtrZ-Z), PB3X-9C (PtrZ-I) and PBlX-2AA(APTRZ) with or without the YEp24 vector were unable to use the dipeptides Lys-Leu, Lys-Met, Lys-Lys, His-Leu, LeuLeu, or His-Lys to satisfy the auxotrophic requirements for amino acids. S. cerevisiae strains PB3X-9C, PBlX-9B or PB1 X-2AA transformed with plasmid pMB3 were able to use all the dipeptides mentioned above as substrates to satisfy corresponding amino acid auxotrophies in appropriately supplemented media (data not shown). The wild-type strain, PB1 X-2A, with or without the vector YEp24, was able to grow on all of the dipeptide substrates tested.
Sensitivity of S. cerevisiae transformants to toxic compounds
The mutant strain PB1 X-9B is sensitive to the toxic amino analogues ethionine and oxalysine, but is resistant to the toxic peptides Ala-Eth and oxalysine-containing di-and tripeptides (Island et al., 1991 ; Perry et al., 1994) . For disk sensitivity assays, lysine was added to the growth medium to supplement auxotrophic requirements. Lysine reverses the toxicity of oxalysine (Table 1) by preventing this amino acid from entering the yeast (Basrai et al., 1992) . Disk sensitivity assays showed that the resistance of the deletion mutant PBlX-2AA to Ala-Eth, Oxa-Gly and Oxa-Leu-Gly was reversed by transformation with plasmid pMB3 (Table 1) . However, the outlines of the zones of inhibition were not very sharp and growth could be observed close to the boundary of the zone for Ala-Eth (Fig. 3) . No toxicity was observed for oxalysine-containing tetra-or pentapeptides toward the S. cerevisiae wild-type or any transformant tested. However, C. albicans ATCC 18804 exhibited sensitivity to oxalysine-containing di-, tri-, tetra-and pentapeptides (data not shown).
S. cerevisitze PBlX-2A(YEp24) was sensitive (8 % of cells were viable), whereas PB1 X-2AA(YEp24) was relatively resistant (80% of cells viable) to the toxic effect of the peptidyl nucleoside polyoxin D (750 pg ml-l) after a 5 h incubation. Under similar conditions S. cerevisiae PB1 X-9B(pMB3) showed an intermediate phenotype between the deletion strains and the wild-type strains, as 32% of the cells were viable after incubation with the drug.
Southern blotting and chromosome mapping of C a m 2
Southern blotting was done to establish whether the cloned fragment of DNA originated from C. albicans genomic DNA, and to determine if there were other homologous genes in C. albicans. Whole-cell DNA was isolated from C. albicans ATCC 18804 and digested with enzymes (PstI, HindIII, and MlUI/HincII) predicted to yield one band on the basis of the restriction map of pMB3 (Fig. la) . DNA was resolved by electrophoresis, and Southern blotting was done as described in Methods. As seen in Fig. 4 , the PCR-derived probe (as described in Fig.  1 b) produced the expected bands for all digests (7.9 kb for PstI digests, 3.1 kb for HindIII digests, and 3.8 kb for MldIHincII double digests) along with a second band in the HindIII digest (5.4 kb). The presence of the unexpected band can be explained by multiple copies or restriction fragment length polymorphism (RFLP) within this diploid organism. The CaPTR2 probe did not hybridize to whole-cell DNA from S. cerevisiae under the same stringency conditions (data not shown). The CaPTR2 gene was mapped to chromosome R that contains the rDNA-containing linkage group (Wickes et al., 1991) by Dr B. B. Magee of University of Minnesota (personal communication ; data not shown).
Nucleotide and deduced amino acid sequences of CaPTR2
The dideoxynucleotide chain-termination method was used to determine the nucleotide sequence of both strands of the complementing region in the plasmid pMC13. nucleotides. The highly conserved consensus sequences of a type I1 intron, consisting of a 5' splice site (GTATGT), a 3' splice site (TAG), and a branch point (TACTAAC), were identified in the region separating the two ORFs (Rymond & Rosbash, 1992) . The subclone pMC13, which contains both exons and the intron, functionally restored the P T R 2 phenotype to mutants, while the subclone, pMC1, which contains the first exon, the intron and 59 nucleotides of the second exon, did not (Fig. 1) . Furthermore, exon 2 encodes a peptide of 148 residues which showed 25-5 YO identity and 59.1 % similarity to the last 148 amino acids of SacPtr2p, implicating a highly conserved region of the protein that is presumably necessary for function. Therefore, based upon this sequence analysis and subcloning data, we propose that the C a P T R 2 gene contains a type I1 intron spanning 84 nucleotides and separating two ORFs of 475 and 148 amino acid residues (Fig. 5) . In contrast, no intron was found in the SacPTR2 gene (Perry e t al., 1994) .
A search of the GenBank database with the BLAST algorithm (Altshul et al., 1990) showed that three proteins identified as peptide transporters had sequence similarity to CaPtr2p. CaPtr2p exhibited 30% identity and 56.9% similarity to SacPtr2p from S. cerevisiae (Perry e t al., 1994) , 32% identity and 54.8% similarity to AtPtr2p from Arabidopsis tbaliana (Steiner e t al., 1994) , and 24.1 YO identity and 51.4% similarity to PepTlp from rabbit intestines (Fei et al., 1994) . These sequences were compiled under the Pileup program (Feng & Doolittle, 1987) of the Genetics Computer Group (GCG) database (Devereux et al., 1984) and conserved sequences identified (Fig. 6 ).
DISCUSSION
The data presented in this paper show that a C. albicans gene, CaPTR2, has been cloned which functionally complements 5'. cerevisiae peptide transport mutants of the P T R 2 complementation group. CaP TR2 complements two independently isolated ptr2 mutants as well as a S. cerevisiae strain which is deleted in the P T R 2 gene. Due to 
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Southern blot analyses demonstrated each of the predicted bands as well as an additional band in the Hind111 digest. The unexpected band can be explained by RFLP between the two chromosomal homologues or alternatively by multiple copies of C a P T R 2 on the R chromosome. We favour the former explanation because all other digests produced their respective single bands. Both M l d and PstI restriction sites reside well outside the ORF and we believe it unlikely that two enzymes would produce the same band in multiple copies of a gene. RFLP has been demonstrated previously at the EXG7 (Chambers e t al., 1993) and U R A 3 loci (Kelly et al., 1987) in C. albicans.
The nucleotide sequence from pMC13 predicts a protein of 623 amino acids with a molecular mass of 70 kDa and a PI of 6.4. Computer-assisted analysis of the structure revealed an amino terminus of 63 hydrophilic residues followed by 12 hydrophobic segments of approximately 20 amino acids in length, with intervening hydrophilic segments and a carboxy terminus consisting of 43 hydrophilic residues. An almost identical hydropathy plot was seen in peptide transporters in 5. cerevisiae and A . tbaliana (Steiner et al., 1994) . Furthermore, computerassisted predictions of protein secondary structure revealed that the hydrophobic regions (putative transmembrane domains) consisted of p-sheet-forming regions rather than a-helices. Predicted B-sheet formation in membrane proteins has been reported previously in the S. cerevisiae proteins Ptr2p (Perry et al., 1994) and DalSp, an allantoin permease (Rai e t al., 1988) .
The existence of multiple peptide permeases based on growth and toxicity studies has been reported previously in C. albicans McCarthy et al., 1985; Payne et al., 1991) , while S. cerevisiae has been shown by genetic experiments to possess only a di-tripeptide transporter (Perry e t al., 1994) . The fact that PBlX-9B transformed with pMB3 is resistant to oxalysine-containing tetra-and pentapeptides, whereas the wild-type C.
albicans 18804 is sensitive to toxic tetra-and pentapeptides, suggests that CaPtr2p is only capable of transporting diand tripeptides, although a size limitation may be imposed on CaPtr2p due to its expression in the S. cerevisiae heterologous host. Therefore, more genetic studies must be undertaken to determine whether multiple C. albicans peptide transport genes exist. Cloning of a C. albicans oligopeptide transporter gene by functional expression in S. cerevisiae is currently being attempted in our laboratory.
A BLAST search identified significant similarity between CaPtr2p and the peptide transporters SacPtr2p of S. cerevisiae, AtPtr2p of A . tbaliana, and PepTlp of rabbit intestine (Fig. 6) . In contrast, neither the S. cerevisiae STE6 gene, which exports the peptide mating pheromone afactor from MATa cells (Kuchler etal., 1989; McGrath & Varshavsky, 1989) , nor the OPP operon of Salmonella gpbimurium (Hiles et al., 1987) , which encodes the peptide transport system of enteric bacteria, hybridized to C. albicans DNA as determined by Southern blotting (data not shown). Furthermore, a BLAST search revealed no similarity between CaPtr2p and a C. albicans multipledrug-resistance protein product containing 12 transmembrane domains (Ben-Yaacov e t al., 1994). This analysis has led us to the identification of a new family of predominately eukaryotic peptide transporters (Steiner et al. , 1994) .
In summary, we report here the identification, cloning, and sequencing of a C. albicans gene that can functionally complement a S. cerevisiae peptide transport mutant. We have demonstrated that S. cerevisiae is a model recipient for peptide transporters and could provide an invaluable tool to evaluate peptide transport in other fungi and from complex organs, such as the intestine and the kidney, under controlled conditions. Such studies should prove invaluable in the rational design of peptide-based drugs.
